Loading...
At this year's annual meeting of the American Society of Clinical Oncology (ASCO 2016), held June 3 to 7 in Chicago, investigators discussed the latest findings in cancer research. The editors of NEJM Journal Watch Oncology and Hematology were on hand to report highlights of the conference. Here, Editor-in-Chief William J. Gradishar, MD, reviews key presentations on new breast cancer treatments. All meeting abstracts can be viewed in the ASCO meeting library).
A study by Goss and colleagues presented in the Plenary session suggested that extending the duration of treatment with the aromatase inhibitor letrozole for as long as 10 years may further reduce the risk for disease recurrence…